Mirion Technologies, Inc.

Mirion provides essential protection that enables the use of radiation to advance science, industry, and medicine. For over 60 years, Mirion and its predecessor companies have offered products, services, and software that allow customers to safely utilize ionizing radiation for applications benefiting health, safety, vitality, and technological progress. The company is a global leader in radiation safety and innovation, combining expertise with precise technologies. Mirion's operations are headquartered in Atlanta, Georgia, with additional operations in Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, Japan, and South Korea. Mirion operates through two reporting segments: Nuclear & Safety and Medical. The Nuclear & Safety segment supports advancements in nuclear energy and critical radiation safety, measurement, and analysis across nuclear power facilities, laboratories, research, and other industrial markets like defense. The Medical segment focuses on enhancing the quality and safety of cancer care delivery and supports applications in medical diagnostics and practitioner safety. Mirion's products, software, and services are sold directly and indirectly to a diverse range of customers. These include active nuclear power reactors, innovators in Small Modular Reactor (SMR) design, universities, numerous international government and supranational agencies, 23 of the 32 NATO militaries, national laboratories, environmental laboratories, research institutes, industrial companies, radiopharmaceutical drug manufacturers, hospitals, cancer centers, and small office healthcare providers.